13 records – page 1 of 1.

Select Title Policy Type Year
EspAddText
EspRemoveText
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use Policy endorsement 2021
EspAddText
EspRemoveText
Health Canada consultation on Canadian drugs and substances strategy Response to consultation 2018
EspAddText
EspRemoveText
Implementation of National Pharmacare Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on tobacco products regulations (plain and standardized appearance) Response to consultation 2018
EspAddText
EspRemoveText
Support life-saving supervised consumption and overdose prevention sites: open letter to Premier Doug Ford and Health Minister Christine Elliott Policy endorsement 2018
EspAddText
EspRemoveText
Health Canada consultation on regulatory amendments regarding tramadol Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on restriction of marketing and advertising of opioids Response to consultation 2018
EspAddText
EspRemoveText
Consultation on proposed front-of-package labelling Response to consultation 2018
EspAddText
EspRemoveText
Bill C-45: The Cannabis Act Parliamentary submission 2018
EspAddText
EspRemoveText
CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts Parliamentary submission 2018
EspAddText
EspRemoveText
Proposed approach to the regulation of cannabis Response to consultation 2018
EspAddText
EspRemoveText
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health Parliamentary submission 2013
EspAddText
EspRemoveText
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal Parliamentary submission 2013

13 records – page 1 of 1.